What does Voyager Acquisition Corp./Cayman Islands do?

Voyager Acquisition Corp./Cayman Islands is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in E9. It is registered with the SEC under CIK 0002006815 and trades on NASDAQ under the ticker VACHW.

Is Voyager Acquisition Corp./Cayman Islands profitable?

Voyager Acquisition Corp./Cayman Islands was profitable in FY2025, reporting net income of $8.99M. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Voyager Acquisition Corp./Cayman Islands made?

Voyager Acquisition Corp./Cayman Islands has filed 87 documents with the SEC since 2024. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Voyager Acquisition Corp./Cayman Islands

VACHW NASDAQ CIK: 0002006815 Biological Products, (No Diagnostic Substances) Inc. in E9

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 87 filings →

Form	Description	Date
425	425	Mar 18, 2026
8-K	8-K	Mar 18, 2026
425	425	Mar 12, 2026
10-K	10-K	Mar 10, 2026
8-K	8-K	Feb 27, 2026
425	425	Feb 27, 2026
424B3	424B3	Feb 19, 2026
SCHEDULE 13G/A	—	Feb 17, 2026
EFFECT	—	Feb 17, 2026
SCHEDULE 13G/A	—	Feb 13, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Voyager Acquisition Corp./Cayman Islands. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: $8.99M (FY2025)
Total Assets: $270.06M (FY2025)
Operating Income: ($1.79M)

Full financials →

Details

CIK: 0002006815
Ticker: VACHW
Exchange: NASDAQ
Incorporated: E9
First Filing: 2024
Total Filings: 87

Biological Products, (No Diagnostic Substances) rankings →